These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4561511)

  • 21. Cytochemical localization of type-A and -B monoamine oxidase in the rat pineal gland.
    Masson-Pévet M; Pévet P
    Cell Tissue Res; 1989 Feb; 255(2):299-305. PubMed ID: 2924333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals.
    Iversen LL; Glowinski J; Axelrod J
    J Pharmacol Exp Ther; 1966 Feb; 151(2):273-84. PubMed ID: 5932603
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacology of the adrenergic system. I. Drug interference with formation, catabolism, storage and release of catecholamines in the adrenergic system].
    Ariëns EJ
    Ned Tijdschr Geneeskd; 1970 Jan; 114(5):198-211. PubMed ID: 4391830
    [No Abstract]   [Full Text] [Related]  

  • 24. Properties of monoamine oxidase in mouse neuroblastoma N1E-115 cells.
    Donnelly CH; Richelson E; Murphy DL
    Biochem Pharmacol; 1976 Jul; 25(14):1639-43. PubMed ID: 942463
    [No Abstract]   [Full Text] [Related]  

  • 25. CONCEPT OF THE NEUROCHEMICAL TRANSDUCER AS AN ORGANIZED MOLECULAR UNIT AT SYMPATHETIC NERVE ENDINGS.
    BRODIE BB; COSTA E
    Act Nerv Super (Praha); 1963 Jul; 5():264-79. PubMed ID: 14055185
    [No Abstract]   [Full Text] [Related]  

  • 26. Submicroscopic localization of norepinephrine in sympathetic nerves of rat pineal.
    Bondareff W; Gordon B
    J Pharmacol Exp Ther; 1966 Jul; 153(1):42-7. PubMed ID: 5921356
    [No Abstract]   [Full Text] [Related]  

  • 27. Tyrosine hydroxylase activity increases in pineal sympathetic nerves after depletion of neuronal serotonin.
    Rubio MC; Jaim-Etcheverry G; Zieher LM
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(1):75-8. PubMed ID: 23499
    [No Abstract]   [Full Text] [Related]  

  • 28. Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
    Pettinger WA; Korn A; Spiegel H; Solomon HM; Pocelinko R; Abrams WB
    Clin Pharmacol Ther; 1969; 10(5):667-74. PubMed ID: 5808462
    [No Abstract]   [Full Text] [Related]  

  • 29. The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves.
    Axelrod J; Kopin IJ
    Prog Brain Res; 1969; 31():21-32. PubMed ID: 4900113
    [No Abstract]   [Full Text] [Related]  

  • 30. Density of sympathetic nerve terminals in human superficial temporal arteries: potassium permanganate fixation and monoamine oxidase histochemistry.
    Oka N; Akiguchi I; Matsubayashi K; Kameyama M; Maeda T; Kawamura J
    Stroke; 1987; 18(1):229-33. PubMed ID: 2433818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. 3. THE MONOAMINE NERVE TERMINAL.
    FUXE K
    Z Zellforsch Mikrosk Anat; 1965 Feb; 65():573-96. PubMed ID: 14263017
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat.
    Baldessarini RJ; Lipinski JF; Chace KV
    Biochem Pharmacol; 1972 Jan; 21(1):77-87. PubMed ID: 5058704
    [No Abstract]   [Full Text] [Related]  

  • 33. The homogeneity of pig brain mitochondrial monoamine oxidase.
    Tipton KF; Spires IP
    Biochem Pharmacol; 1968 Oct; 17(10):2137-41. PubMed ID: 5696881
    [No Abstract]   [Full Text] [Related]  

  • 34. HISTOCHEMICAL AND BIOCHEMICAL DETECTION OF MONOAMINE RELEASE FROM BRAIN NEURONS.
    CARLSSON A; DAHLSTROEM A; FUXE K; LINDQVIST M
    Life Sci (1962); 1965 Apr; 4():809-16. PubMed ID: 14343933
    [No Abstract]   [Full Text] [Related]  

  • 35. Distribution of types A and B monoamine oxidases in discrete brain regions, pineal and pituitary glands of the golden hamster.
    Edwards DJ; Malsbury CW
    Life Sci; 1977 Oct; 21(7):1009-14. PubMed ID: 927016
    [No Abstract]   [Full Text] [Related]  

  • 36. [Regulation of monoamine oxidase activity by glucocorticoids].
    Parvez H; Parvez S
    C R Acad Hebd Seances Acad Sci D; 1972 Feb; 274(6):919-21. PubMed ID: 4336099
    [No Abstract]   [Full Text] [Related]  

  • 37. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. 3. Selective increase of norepinephrine in the rat pineal gland consecutive to depletion of neuronal 5-hydroxytryptamine.
    Jaim-Etcheverry G; Zeiher LM
    J Pharmacol Exp Ther; 1971 Jul; 178(1):42-8. PubMed ID: 4253294
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pineal gland and brain structures monoamine oxidase activity in rats of different age].
    Razygraev AV; Arutiunian AV
    Adv Gerontol; 2008; 21(3):402-5. PubMed ID: 19432173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of enzyme activities and a circadian rhythm in pineal gland serotonin: evidence for a nonretinal pathway of light to the pineal gland of newborn rats.
    Snyder SH
    Adv Pharmacol (1962); 1968; 6(Pt A):301-5. PubMed ID: 5664053
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of metopirone and adrenalectomy on the regulation of the enzymes monoamine oxidase and catechol-O-methyl transferase in different brain regions.
    Parvez H; Parvez S
    J Neurochem; 1973 Apr; 20(4):1011-20. PubMed ID: 4697866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.